Antimicrobial resistance: a deadly burden no country can afford to ignore.
Birnbaum
David
D
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002170:Canada; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004352:Drug Resistance, Microbial; D004363:Drug Utilization; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D014481:United States
D000900:Anti-Bacterial Agents